(22) observed that there was no association between tumor margin and TILs level, but they divided the TIL levels into three groups (low: <10%, intermediate: 10-50%, high: >50%) among patients with ER-negative/HER2-positive BC. This evidence concerns the gene ERBB2 and breast cancer.